NEK2 and cancer: Other scholars have demonstrated the effects of mitotic kinases such as Nek2 and Mps1 (TTK) on EMT, focusing on AuroraA, AuroraB, Bub1 and Hec1 (high expression in cancer) as potential targets for cancer therapeutic intervention through their impact on EMT.